Katarina Petrakova
Brno, JM, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
The impact of online-delivered controlled physical activity on cardiorespiratory fitness and heart rate variability in breast cancer survivors.
Journal: Scientific reports
Published: January 15, 2026
Young adult cancer patients in the Czech Republic: Is there a need for national guidelines?
Journal: Casopis lekaru ceskych
Published: August 15, 2025
The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024).
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: November 08, 2024
The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024).
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 22, 2024
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 22, 2023
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.
Journal: Breast cancer research : BCR
Published: January 10, 2023
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 30, 2022
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 04, 2022
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy.
Journal: Diagnostics (Basel, Switzerland)
Published: June 19, 2022
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: April 25, 2022
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: March 09, 2022
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer.
Journal: Cancers
Published: March 08, 2022
Last Updated: 09/26/2026